Lower Atrial Fibrillation Risk With Sodium-Glucose Cotransporter 2 Inhibitors Than With Dipeptidyl Peptidase-4 Inhibitors in Individuals With Type 2 Diabetes: A Nationwide Cohort Study
在2型糖尿病患者中,钠-葡萄糖协同转运蛋白2抑制剂比二肽基肽酶-4抑制剂更能降低房颤风险:一项全国性队列研究
期刊:Korean Circulation Journal
影响因子:3.1
doi:10.4070/kcj.2023.0234
Kim, Min; Ha, Kyoung Hwa; Lee, Junyoung; Park, Sangshin; Oh, Kyeong Seok; Bae, Dae-Hwan; Lee, Ju Hee; Kim, Sang Min; Choi, Woong Gil; Hwang, Kyung-Kuk; Kim, Dong-Woon; Cho, Myeong-Chan; Kim, Dae Jung; Bae, Jang-Whan